Variation in human herpesvirus 6B telomeric integration, excision and transmission between tissues and individuals by Wood, Michael L. et al.
 1 
Variation in Human Herpesvirus 6B telomeric integration, excision and transmission between 1 
tissues and individuals 2 
 3 
Wood, M.L.1, Veal, C.D.1, Neumann, R.1, Suárez, N.M.2, Nichols, J.2, Parker, A.J. 1, Martin, D.1, 4 
Romaine, S.P.R3, 4, Codd, V. 3, Samani, N.J.3, Voors, A.A. 5, Tomaszewski, M.6, Flamand, L.7, Davison, 5 
A.J. 2, and Royle, N.J. 1 6 
 7 
1 Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom. 8 
2 MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. 9 
3 Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom. 10 
4 NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom. 11 
5 University of Groningen, Department of Cardiology, University Medical Center Groningen, 12 
Groningen, The Netherlands.  13 
6 Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and 14 
Health, University of Manchester, Manchester, United Kingdom. 15 
7 Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université 16 
Laval, Quebec City, Québec, Canada 17 
 18 
Running Title:  19 
















Abstract  35 
Human herpesviruses 6A and 6B (HHV-6A/6B) are ubiquitous pathogens that persist lifelong in latent 36 
form and can cause severe conditions upon reactivation. They are spread by community-acquired 37 
infection of free virus (acqHHV6A/6B) and by germline transmission of inherited chromosomally-38 
integrated HHV-6A/6B (iciHHV-6A/6B) in telomeres. We exploited a hypervariable region of the HHV-39 
6B genome to investigate the relationship between acquired and inherited virus and revealed 40 
predominantly maternal transmission of acqHHV-6B in families. Remarkably, we demonstrate that 41 
some copies of acqHHV-6B in saliva from healthy adults gained a telomere, indicative of integration 42 
and latency, and that the frequency of viral genome excision from telomeres in iciHHV-6B carriers is 43 
surprisingly high and varies between tissues. In addition, newly formed short telomeres generated 44 
by partial viral genome release are frequently lengthened, particularly in telomerase-expressing 45 
pluripotent cells. Consequently, iciHHV-6B carriers are mosaic for different iciHHV-6B structures, 46 
including circular extra-chromosomal forms that have the potential to reactivate. Finally, we show 47 
transmission of an HHV-6B strain from an iciHHV-6B mother to her non-iciHHV-6B son. Altogether 48 
we demonstrate that iciHHV-6B can readily transition between telomere-integrated and free virus 49 
forms.  50 
 51 
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Introduction 57 
Human herpesviruses 6A and 6B (HHV-6A/6B; species Human betaherpesvirus 6A and 58 
Human betaherpesvirus 6B) are closely related viruses, sharing approximately 90% sequence identity 59 
(Ablashi et al, 2014). Their genomes comprise a unique region (U) of approximately 140 kb flanked 60 
on each side by a direct repeat (DR) of approximately 8 kb (DRL on the left and DRR on the right). A 61 
tandem repeat reiteration is located near each end of DR. T1 at one end of DR, consists of 1-8 kb of 62 
telomere (TTAGGG) and degenerate telomere-like repeats (Huang et al, 2014; Lindquester & Pellett, 63 
1991; Zhang et al, 2017). T2 at the other end of DR is much shorter and contains only (TTAGGG) 64 
repeats (Achour et al, 2009; Zhang et al., 2017). HHV-6A/6B have the capacity to integrate into 65 
human telomeres, most likely through a homology-dependent recombination mechanism facilitated 66 
by the perfect telomere repeats in T2 (Arbuckle et al, 2010; Wallaschek et al, 2016b). The precise 67 
integration mechanism has not been defined, and searches for regulatory viral or host factors are 68 
underway (Gilbert-Girard et al, 2017; Gilbert-Girard et al, 2020; Wallaschek et al, 2016a; Wight et al, 69 
2018). 70 
HHV-6A/6B infect over 90% of the global population in early childhood, this usually 71 
manifests with mild symptoms but nevertheless often requires medical attention (Asano et al, 1994; 72 
Hall et al, 1994; Kondo et al, 1993; Ward & Gray, 1994; Zerr et al, 2005). As with most herpesviruses, 73 
HHV-6A/6B enter lifelong latency following primary infection, and the most serious impacts on 74 
health appear to occur when the virus reactivates. Reactivation of free virus acquired in the 75 
community (acqHHV-6A/6B) has been shown to cause viral encephalitis, drug-induced 76 
hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) 77 
and acute graft-versus-host disease (aGVHD) (Aihara et al, 2003; Eshki et al, 2009; Pritchett et al, 78 
2012; Prusty et al, 2018; Yao et al, 2010; Yoshikawa et al, 2006). In addition, HHV-6A infection has 79 
been associated with multiple sclerosis and other chronic neurological conditions (Yao et al., 2010). 80 
Herpesviruses typically achieve latency by forming circular DNA episomes within specific cell types, 81 
but HHV-6A/6B episomes have not been detected and it has been proposed that latency of these 82 
viruses is achieved through telomeric integration (Arbuckle et al., 2010).  83 
As a result of historical germline integrations into telomeres, approximately 1% of the 84 
population carries inherited chromosomally integrated HHV-6A/6B (iciHHV-6A/6B), usually with a 85 
full-length copy of the viral genome in every cell (Arbuckle et al., 2010; Daibata et al, 1999; Huang et 86 
al., 2014; Leong et al, 2007; Morris et al, 1999; Tanaka-Taya et al, 2004). HHV-6A/6B appear to have 87 
the potential to integrate into any telomere however, most contemporary instances of iciHHV-6A/6B 88 
are derived from a relatively small number of ancient integrations in a limited number of 89 
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chromosome ends (Aswad et al, 2021; Greninger et al, 2018; Kawamura et al, 2017; Liu et al, 2018; 90 
Liu et al, 2020; Miura et al, 2018; Tweedy et al, 2016; Zhang et al., 2017). For example, iciHHV-6B is 91 
commonly found integrated into the telomere on the short arm of chromosome 17 (17p) in 92 
populations of European descent and iciHHV-6A is commonly found in the long arm of chromosome 93 
22 (22q) in Japan.  Integration sites have been determined in a variety of studies by one or a 94 
combination of the following methods: Fluorescent in situ hybridisation (FISH); PCR amplification 95 
from subterminal sequences adjacent to human telomeres (subtelomere) into the viral genome; 96 
inverse PCR and comparison with known subtelomere sequences; long-read sequencing; optical 97 
genome mapping (Daibata et al., 1999; Huang et al., 2014; Luppi et al, 1998; Nacheva et al, 2008); 98 
(Aswad et al., 2021; Greninger et al., 2018; Kawamura et al., 2017; Liu et al., 2020; Miura et al., 99 
2018; Tweedy et al., 2016; Wight et al, 2020; Zhang et al., 2017). 100 
Detection of viral gene expression in some iciHHV-6A/6B carriers has raised the possibility of 101 
a deleterious impact on the individual’s health over their lifetime (Huang et al., 2014; Peddu et al, 102 
2019; Strenger et al, 2014). Similarly, the presence of a large viral genome within in a telomere has 103 
been shown to cause localised instability that may influence telomere DNA damage signalling and 104 
function (Huang et al., 2014; Wood & Royle, 2017; Zhang et al, 2016). Recent studies have also 105 
indicated an association between iciHHV-6A/6B and angina pectoris (Gravel et al, 2015); unexplained 106 
infertility (Miura et al, 2020); an increased risk of aGVHD following haematopoietic stem cell 107 
transplantation when either the donor or recipient has iciHHV-6A/6B (Hill et al, 2017; Weschke et al, 108 
2020); complications following solid organ transplantation when there was iciHHV-6A/6B 109 
donor/recipient mismatch (Bonnafous et al, 2018; Bonnafous et al, 2020; Petit et al, 2020); and 110 
possibly an increased risk of pre-eclampsia (Gaccioli et al, 2020). 111 
There is increasing evidence that iciHHV-6A/6B genomes can reactivate fully (Endo et al, 112 
2014) and then be transmitted as acqHHV-6A/6B (Gravel et al, 2013; Hall et al, 2010), but the chain 113 
of events leading to reactivation is unknown. Telomeres are terminated by a single-stranded 3′   114 
overhang that can strand-invade into the upstream double-stranded telomeric DNA to form a 115 
telomere loop (t-loop) (Doksani et al, 2013; Griffith et al, 1999; Wang et al, 2004). This secondary 116 
structure is stabilised by TRF2, a component of the Shelterin complex that binds to double-stranded 117 
telomere repeats, and plays a protective role by preventing the ends of linear chromosomes being 118 
detected as double-strand breaks and inappropriately repaired (de Lange, 2018; Schmutz et al, 2017; 119 
Stansel et al, 2001; Van Ly et al, 2018). However, t-loops can be excised as telomere repeat-120 
containing t-circles (Pickett et al, 2009; Pickett et al, 2011; Sarek et al, 2015; Tomaska et al, 2019) by 121 
the SLX1-4 complex, which is a structure-specific endonuclease (Fekairi et al, 2009; Vannier et al, 122 
2012; Wan et al, 2013), and unregulated excision of t-loops results in critically short telomeres (Deng 123 
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et al, 2013; Pickett et al., 2011; Rivera et al, 2017). We and others have proposed that release of the 124 
viral genome is a prerequisite for reactivation of iciHHV-6A/6B and that this release is driven by 125 
normal t-loop processing (Huang et al., 2014; Prusty et al, 2013; Wood & Royle, 2017). 126 
Here, we have investigated iciHHV-6A/6B genomes (with a particular focus on iciHHV-6B), 127 
their associated telomeres and their relationships to acqHHV-6B genomes in families and 128 
communities. We exploited the proximal hypervariable region of T1 (pvT1) in the HHV-6B genome to 129 
distinguish between acqHHV-6B strains and to predict relationships between iciHHV-6B and acqHHV-130 
6B in families. For the first time, we have detected acqHHV-6B telomeric integration in saliva DNA 131 
from healthy adults. The frequency of partial or complete iciHHV-6B excision varied between 132 
germline and somatic cells, with notably high frequencies in two pluripotent cell lines, and we 133 
present evidence of HHV-6B transmission from an iciHHV-6B carrier mother to her non-iciHHV-6B 134 
son. In summary, our study demonstrates that HHV-6B can readily transition between iciHHV-6B and 135 
acqHHV-6B forms, and vice versa.  136 
 137 
Results 138 
DRR-pvT1 tracking of HHV-6B transmission 139 
To explore the relationship between iciHHV-6A/6B and acqHHV-6A/6B, we identified a 140 
genomic marker (pvT1) capable of distinguishing viral strains by nested PCR and sequencing. To 141 
investigate DRR-pvT1 specifically, the first round of amplification was achieved using a primer 142 
anchored at the end of U near DRR and a primer in DR on the other side of T1 (Figure 1A). The 143 
second round of amplification and subsequent sequencing involved a primer (TJ1F) anchored in a 144 
short, conserved sequence approximately 400 bases into the T1 telomere-like repeat array and a 145 
second primer in DR (DR421R), adjacent to T1. A total of 102 DNA samples were analysed: iciHHV-6B 146 
from 39 individuals (38.2%) and acqHHV-6B from 63 (61.8%) individuals (Supplementary File 1). The 147 
analysis showed that DRR-pvT1 can be divided into three regions from the DR421 primer (proximal, 148 
central and distal), with most of the variation being due to differences in the number and 149 
distribution of telomere (TTAGGG) and degenerate telomere-like repeats (predominantly CTATGG 150 
and CTAGGG) in the proximal and central regions. Patterns of repeats are shown for a subset of 151 
samples in Figure 1B, and the complete dataset is provided in Figure 1 – figure supplement 1. 152 
Among the 102 repeat patterns, 93 were different from each other, and 90 of these were 153 
detected in only a single donor or family. Amongst the 12 repeat patterns shared between 154 
individuals, eight were identical to each other, and seven of these were from closely related viral 155 
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genome sequences in iciHHV-6B carriers with a shared 9q integration. The eighth was found in saliva 156 
DNA from an individual (SAL030) with acqHHV-6B (Figure 1 – figure supplement 1). Among the 157 
remaining four repeat patterns, two were in iciHHV-6B samples (NWA008 and DER512) that share 158 
the same 17p integration site, and two were in acqHHV-6B samples (SAL023 and TEL-FA G1P1). 159 
Remarkably, the pvT1 repeat pattern was different in almost every unrelated individual with 160 
acqHHV-6B (61/63, 96.8%) and also in the majority of iciHHV-6B individuals (30/39, 77.0%; 29/31, 161 
93.5%, when the entire 9q iciHHV-6B group was excluded).  162 
Although DRR-pvT1 is highly variable among acqHHV-6B genomes in unrelated individuals, 163 
this is not the case within families (Figure 1C, Figure 1 – figure supplement 2). Saliva DNA was 164 
analysed from 36 individuals in eight families (without iciHHV-6A/6B) and DRR-pvT1 was successfully 165 
amplified and sequenced from 34 of them (94%). Eighteen of the 20 children (90%) in these families 166 
had the same repeat pattern as one of their parents, presumably as a result of acqHHV-6B 167 
transmission directly from a parent (maternal transmission in six of the eight families and paternal 168 
transmission in one) or indirectly via a sibling (Figure 1 – figure supplement 2). In contrast, the 169 
analysis revealed that one child in each of two families must have contracted acqHHV-6B from 170 
outside their immediate family (TEL-FC G2P2 and TEL-FM G2P1, Figure 1 – figure supplement 2). As a 171 
control, analysis of DRR-pvT1 repeat patterns in iciHHV-6B carriers in the CEPH1375 family 172 
demonstrated the stability of the repeat patterns across three generations (Figure 1C). All six 173 
individuals, shown previously to be iciHHV-6B carriers (Huang et al., 2014), shared an identical 174 
pattern indicating that DRR-pvT1 in iciHHV-6B does not necessarily acquire mutations from one 175 
generation to the next. In summary, DRR-pvT1 analysis was used successfully to distinguish HHV-6B 176 
strains and to monitor transmission of iciHHV-6B and acqHHV-6B between family members. 177 
 178 
Phylogeny of iciHHV-6A/6B in relation to integration events 179 
Progress has been made recently in sequencing iciHHV-6A/6B and acqHHV-6A/6B genomes 180 
by generating overlapping PCR amplicons (Zhang et al., 2017) or an oligonucleotide hybridisation 181 
enrichment process (Aswad et al., 2021; Greninger et al., 2018; Telford et al, 2018). However, the 182 
evolutionary histories of iciHHV-6A/6B genomes and their relationships with acqHHV-6A/6B 183 
genomes remain unclear. Moreover, it is not known how many founder germline integration events 184 
have occurred. To expand the data required to answer such questions, we screened various cohorts 185 
and families to identify additional iciHHV-6A/6B-positive samples, and then selected several key 186 
samples for viral genome sequencing using the overlapping PCR amplicon approach (Supplementary 187 
File 1) (Huang et al., 2014; Zhang et al., 2017). These samples included five iciHHV-6A and four 188 
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iciHHV-6B samples from the BIOSTAT-CHF cohort, four other iciHHV-6A samples, one iciHHV-6A cell 189 
line (HGDP00628 (Huang et al., 2014)), and a pluripotent cell line (d37) from an iciHHV-6B carrier. In 190 
total, ten iciHHV-6A and five iciHHV-6B genomes were sequenced. 191 
 Distance-based phylogenetic networks of iciHHV-6A/6B and acqHHV-6A/6B genomes were 192 
generated, including the 15 newly sequenced iciHHV-6A/6B genomes and iciHHV-6A/6B genomes 193 
representing previously identified clades and integration sites (Figure 2, Supplementary File 1). 194 
These networks reinforce previous findings (Aswad et al., 2021; Greninger et al., 2018; Tweedy et al., 195 
2016; Zhang et al., 2017) showing that the majority of iciHHV-6A genomes in European and North 196 
American carriers (including the ten newly sequenced) originate from three integration events at 197 
17p, 18q and 19q, with the time to the most recent common ancestor estimated at 23 to 105 198 
thousand years ago (Figure 2A, Supplementary File 2). The networks also confirm that iciHHV-6B 199 
carriers with European and North America ancestry originate from a larger number of integration 200 
events that occurred more recently (21 to 25 thousand years ago; Supplementary File 2) (Aswad et 201 
al., 2021; Greninger et al., 2018; Zhang et al., 2017). Inclusion of the newly sequenced iciHHV-6B 202 
genomes added two new iciHHV-6B clades to the phylogenetic network, each defined by a distinct 203 
integration site (Figure 2B). As a consequence of the complex evolution of subterminal sequences in 204 
the human genome (Riethman, 2008), the chromosomal locations in these iciHHV-6B clades will 205 
require further verification by an independent method, but they represent two more independent 206 
germline telomeric integration events. 207 
As an aid to analysing the increasing number of HHV-6A/6B genome sequences, we 208 
developed HHV-6 Explorer (https://www.hhv6explorer.org/), which is an online interface for 209 
monitoring clade-specific variation in DNA and predicted protein sequences. An analysis of sequence 210 
variation in relation to integration site using this tool produced new insights, for example by 211 
demonstrating that two potentially inactivating mutations, U14 in an iciHHV-6B clade and in U79 in 212 
an iciHHV-6A clade, must have arisen after integration (Figure 2 – figure supplement 1). 213 
 214 
Predicting chromosomal iciHHV-6B integration sites from DRR-pvT1 repeat patterns 215 
To explore whether DRR-pvT1 repeat patterns reflect the phylogenetic relationships between 216 
iciHHV-6B genomes, 19 for which DNA was available, were subjected to DRR-pvT1 analysis. The 217 
results show that iciHHV-6B genomes with a high degree of overall sequence similarity also shared 218 
similar DRR-pvT1 repeat patterns (Figure 3A). For example, individuals with 9q iciHHV-6B have a 219 
characteristic (CTATGG-TTAGTG-CTATGG) motif (pink-cyan-pink repeats) in the central region of DRR-220 
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pvT1, as well as a rare (TTAGAG) repeat (peach) that is found infrequently outside this group. Also, 221 
viral sequences assigned to the 17p (major) iciHHV-6B group by genome sequence identity and 222 
shared 17p subtelomere-iciHHV-6B junction sequences (HGDP01065, DER512, 801018 and 223 
ORCA1622) (Zhang et al., 2017) had similar DRR-pvT1 repeat patterns with a characteristic (GTAGTG)  224 
(blue) repeat at the fifth position, replacing the (TTAGTG) (cyan) repeat seen in almost all other pvT1 225 
repeat patterns  (Figure 3A, Figure 1 – figure supplement 1,  Supplementary File 3).  226 
From these observations, we hypothesised that DRR-pvT1 repeat patterns may be used to 227 
predict both the integration site for newly identified iciHHV-6B carriers and the identity of closely 228 
related viral strains, without the need to sequence viral genomes. Based on similarity between DRR-229 
pvT1 repeat patterns, the integration site was predicted for nine iciHHV-6B genomes for which 230 
genome sequences were not available (Figure 3A). For example, the repeat patterns in YOR546, CRL-231 
1730 and 6-iciHHV-6B were identical or almost identical to those in a large group of iciHHV-6B 232 
genomes with a 9q integration site (Nacheva et al., 2008; Shioda et al, 2018). PCR amplification of 233 
the subtelomere-iciHHV-6B junction was used to validate several of the predictions arising from 234 
these results. For example, DRR-pvT1 analysis placed 410005 and 308006 in the same phylogenetic 235 
clade as the 401027 iciHHV-6B genome (Figure 3A, Figure 2), and common ancestry was confirmed 236 
by sequence similarity across the subtelomere-iciHHV-6B junction fragment (amplified by primer 237 
2p2, Figure 3B, 3C, Figure 2) in all three samples. Similarly, the iciHHV-6B genomes in d44, LAT018, 238 
NWA008 and KEN071 share DRR-pvT1 repeat patterns and subtelomere-iciHHV-6B junction 239 
fragments similar to the large group of iciHHV-6B genomes integrated at 17p (17p major) (Figure 3B, 240 
3C, (Zhang et al., 2017)). In summary, the integration sites of iciHHV-6B genomes that had not been 241 
sequenced were predicted based on a high degree of similarity between DRR-pvT1 repeat patterns, 242 
and six of these predictions were subsequently tested and validated by an independent method.  243 
 244 
Chromosomal integration of acqHHV-6B 245 
Telomeric integration provides a means by which acqHHV-6A/6B may achieve latency. 246 
Although de novo integration has been shown to occur in cell culture (Arbuckle et al., 2010; Arbuckle 247 
et al, 2013; Collin et al, 2020; Gilbert-Girard et al., 2020; Gravel et al, 2017; Wallaschek et al., 248 
2016b), there is little evidence that it occurs contemporaneously in vivo (Moustafa et al, 2017). To 249 
investigate this, we collected saliva DNA samples from 52 healthy donors and used triplicate digital 250 
droplet PCR (ddPCR) assays to quantify HHV-6B genome copy number per cell (Figure 4A). Using this 251 
sensitive approach, low-level HHV-6B was detected in 44 samples (84.6%) with a mean value 252 
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0.00145 copies per cell (range 0.0000233–0.0125). Two kidney DNA samples, K1 and K10, were also 253 
positive for HHV-6B at 0.000525 and 0.0124 copies per cell, respectively (Figure 4A, 4D). 254 
Single TElomere Length Analysis (STELA)  is a PCR-based method that amplifies full-length 255 
telomere molecules from a selected chromosome end, determined by the specificity of the primer 256 
located internally to the telomeric repeats (Baird et al, 2003). Typically, multiple STELA reactions, 257 
each containing low quantities of genomic DNA (usually range 250-1000 pg or 38-152 cell 258 
equivalents per PCR), are conducted in parallel and processed by Southern blot hybridisation to 259 
detect amplified telomere molecules of various lengths. The data collected from each STELA reaction 260 
is pooled to estimate average telomere length (Jeyapalan et al, 2008). Previously we used STELA to 261 
detect and measure the length of iciHHV-6A/6B-associated telomeres at DRL-T1 (Huang et al., 2014). 262 
To determine whether some copies of acqHHV-6B are integrated into telomeres, we aimed in this 263 
study to detect these potentially rare events using STELA in samples that had low but measurable 264 
levels of HHV-6B DNA (Figure 4A). Given the low abundance of HHV-6B in these samples the quantity 265 
of saliva DNA added to each STELA PCR was increased (range 2 -5 ng or 300-760 cell equivalents per 266 
PCR) and up to 900 parallel STELA reactions were processed. In addition, an aliquot of each 267 
completed STELA PCR was diluted and subjected to a second round of nested PCR with primers 268 
DR421R and TJ1F to amplify DRL-pvT1. Successful amplification in the second round confirmed that 269 
an HHV-6B-associated telomere had been amplified in the primary STELA round (Figure 4B, 4C). 270 
Sanger sequencing was used to verify the DRL-pvT1 repeat patterns from STELA products matched 271 
that amplified in bulk genomic DNA from the donor. Various steps were taken to avoid false positive 272 
results. These include the use of newly designed STELA primers for these experiments (Figure 4B) 273 
and conducting STELA on genomic DNA from the HT1080 cell line (HHV-6A/6B negative) to check for 274 
potential non-specific amplification from another telomere or elsewhere in the human genome. No 275 
STELA products were generated from HT1080 among 900 STELA reactions, total 4.5g DNA 276 
screened. This two-step STELA procedure, conducted on DNA from six saliva and two kidney samples 277 
identified a small number of amplicons from some samples with acqHHV-6B (Supplementary File 4). 278 
The proportion of HHV-6B genomes from which a telomere was amplified was estimated using the 279 
HHV-6B copy number per cell (determined by ddPCR) and by estimating the number of cell 280 
equivalents of DNA used per STELA reaction, assuming 6.6 pg DNA per cell (Figure 4D, 281 
Supplementary File 4). For the eight samples analysed, an average of 0.95% (range 0–1.98%) of HHV-282 
6B genomes resulted in pvT1 amplification, indicative of telomeric integration.  The low copy 283 
number of HHV-6B in these samples, combined with reduced PCR amplification efficiency of longer 284 
molecules (telomeres in this case), has a stochastic effect on the potential to detect an HHV-6B-285 
associated telomere in each STELA reaction. For these reasons the error rate associated with 286 
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detection of acqHHV-6B-associated telomere is undetermined and the integration frequencies 287 
should be interpreted cautiously.  288 
We then sought to measure the proportion of acqHHV-6B genomes that are not integrated 289 
in saliva samples, using ddPCR to quantify the copy numbers of DR and PAC1. PAC1 and PAC2 are 290 
genome packaging signals located at the end of T1 and T2, respectively (Figure 4B). The linear, 291 
unintegrated genome has two copies of DR and two copies of PAC1 and PAC2, whereas the 292 
integrated genome has two copies of DR but retains only a single copy of PAC1 and PAC2 (Figure 4B) 293 
(Arbuckle et al., 2010) (Huang et al., 2014). As expected, the ratio of DR:PAC1 in an iciHHV-6B sample 294 
(4B-11p15.5) was approximately 2:1, whereas the ratio in acqHHV6-B samples in saliva samples was 295 
approximately 2:2 (Figure 4E). This shows that most acqHHV-6B genomes in saliva samples are not 296 
integrated, consistent with the STELA data that revealed only low level telomeric integration of 297 
acqHHV-6B genomes in saliva DNA samples.  298 
 299 
Partial excision of iciHHV-6B genomes and novel telomere formation at DRL-T2 300 
We showed previously that iciHHV-6A/6B genomes in lymphoblastoid cell lines (LCLs) can be 301 
truncated at DRL-T2, resulting in loss of the terminal DRL and formation of a novel short telomere at 302 
the breakpoint (Huang et al., 2014; Wood & Royle, 2017). We proposed that truncation is achieved 303 
through a t-loop-driven mechanism in which the 3′ G-rich overhang at the end of the telomere 304 
strand invades DRL-T2, facilitating excision of the terminal DRL as a DR-containing t-circle and leaving 305 
a novel telomere at the excision point with a length limited by the length of T2 for the particular 306 
iciHHV-6A/6B genome. For the iciHHV-6B samples used in this study T2 ranged in length from 16 to 307 
31 telomere repeats (96-186 bp). Here, we measured the frequency of iciHHV-6B truncations at DRL-308 
T2 in seven LCLs, nine blood DNAs (from white blood cells), two pluripotent cell lines, three sperm 309 
DNA samples and saliva DNA (Figure 5A, 5B, 5C, Supplementary File 5). The average frequency of 310 
DRL-T2 truncations with novel telomere formation was 1 in 120 cells, but there were significant 311 
differences between DNAs from different cell types. The number of truncations per cell was lowest 312 
in blood and saliva DNA, with an average of 1 in 300 (0.0033 per cell) and 1 in 320 (0.0031), 313 
respectively, and approximately double this in sperm at 1 in 160 cells (0.00627 per cell). An 314 
astonishingly high number of DRL-T2 truncations were observed in LCLs (0.015 per cell) and 315 
pluripotent cells (0.014 per cell), equating to approximately one in every 70 cells. Furthermore, 316 
released circular DR molecules were detected using an inverse PCR approach (Figure 5 – figure 317 
supplement 1A). 318 
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The histone deacetylase inhibitor, trichostatin-A (TSA) has been shown to promote iciHHV-319 
6A reactivation in cell lines and cultured T cells from iciHHV-6A/6B individuals (Arbuckle et al., 2010; 320 
Arbuckle et al., 2013), and also to increase the abundance of t-circles (Zhang et al, 2019). To explore 321 
whether the frequency of truncations with short telomere formation at DRL-T2 could be influenced 322 
by the chromatin state of the iciHHV-6B genome, the 4B-11p15.5 lymphoblastoid cell line was 323 
treated with TSA. The cells were grown in medium supplemented with various concentrations of TSA 324 
for approximately five days, and the DRL-T2 truncation assay (DRL-T2-STELA) was conducted on DNA 325 
extracted from TSA-treated and control cells (Figure 5D). The frequency of truncation events at DRL-326 
T2 increased significantly from 0.0162 to 0.0290 per cell at the highest TSA concentration. This 327 
suggests that iciHHV-6B chromatin conformation influences the chance of t-loop formation at the 328 
telomere-like repeats within the viral genome and subsequent excision events. 329 
As stated above, loss of the terminal DRL via t-loop formation and excision at DRL-T2 was 330 
expected to generate a short novel telomere detected as a STELA fragment consisting of a flanking 331 
region of DRL of approximately 600 bp plus a telomere repeat array limited to the length of the DRL-332 
T2 (Figure 5A). Some of the DRL-T2-STELA amplicons were longer than the expected 0.7-0.9 kb 333 
(Figure 5B). We showed that these amplicons lack DR3 or DR8 sequences (Figure 5E), thus indicating 334 
they are not molecules truncated at different sites within DRL. We hypothesized that the 335 
intermediate length amplicons (Figure 5B) could have arisen by telomerase-mediated lengthening of 336 
newly formed telomeres at the DRL-T2 truncation site. To address this, six of the lengthened 337 
amplicons from three DNA samples (4B-11p15.5, d56 and NWA008) were sequenced. All comprised 338 
the expected flanking sequence followed by a uniform array of (TTAGGG) repeats exceeding the 339 
known length of DRL-T2 for the sample, thus showing that some of the novel telomeres formed at 340 
DRL-T2 had been lengthened (Figure 5 – figure supplement 1B). Telomerase activity was detected at 341 
a low level in the 4B-11p15.5 and other iciHHV-6B LCLs (Figure 5 – figure supplement 1C), consistent 342 
with a telomerase-mediated lengthening of newly formed telomeres. 343 
The percentage of DRL-T2 telomeres that had undergone lengthening varied between the 344 
iciHHV-6B samples and cell types (Figure 5F). The proportion of lengthened telomeres was higher in 345 
the pluripotent cell lines, blood DNA and saliva samples, and lower in the LCLs and sperm samples 346 
(Supplementary File 5). This may reflect the level of telomerase activity in the cells or their 347 
progenitors, but it may also indicate variable responses to extremely short telomeres. 348 
 349 
Partial excision of iciHHV-6B genomes and novel telomere formation at DRR-T1 350 
Processes driven by t-loop formation can also facilitate the release of U in its entirety with a 351 
single DR from iciHHV-6B (reconstituted with both PAC1 and PAC2) as a circular (U-DR) molecule 352 
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(Arbuckle et al., 2013; Borenstein & Frenkel, 2009; Huang et al., 2014; Wood & Royle, 2017). The 353 
reciprocal product of U-DR excision is expected to be a truncation of the iciHHV-6B genome at DRR-354 
T1 with new telomere formation. To explore this, we exploited the variable nature of pvT1. 355 
Differences between DRR-pvT1 and DRL-pvT1 within a single iciHHV-6B genome were found in many 356 
of the iciHHV-6B samples analysed (24/35, 68.6%) (Figure 6A, Figure 6 – figure supplement 1). These 357 
differences were usually a consequence of loss or gain of a small number of repeats, although in 358 
some cases they involved single base substitutions that converted one repeat type to another. These 359 
differences made it possible to measure the frequency of truncations and new telomere formation 360 
at DRR-T1 via a two-step process. 361 
First, the iciHHV-6B-associated telomeres were amplified using STELA with low input of 362 
genomic DNA per parallel reaction (500 pg/reaction) and in the presence of the DR1R primer that 363 
can generate products from a telomere at DRL-T1 (from normal, full-length iciHHV-6B) or DRR-T1 364 
(following U-DR excision). Second, to distinguish between these STELA products, the PCR amplicons 365 
were subjected to nested PCR to amplify DRL-pvT1 and DRR-pvT1 (Figure 6A). The sizes of the pvT1 366 
amplicons indicated whether the STELA products in the primary PCR had been derived from 367 
telomeres at DRL or DRR, and selected sequencing was used to confirm they contained the expected 368 
DRR-pvT1 pattern of repeats (Figure 6B). The size difference between the DRL and DRR-pvT1 369 
amplicons is usually small, influencing the ability to size separate the amplicons. Consequently, ten 370 
iciHHV-6B samples, with larger pvT1 size differences, were selected and truncations at DRR-T1 were 371 
detected in all. In summary, the frequency of newly formed telomeres at DRR-T1 varied between 372 
samples (0.0002–0.0029 per cell; Figure 6C, Supplementary File 6).  373 
 374 
Generation of DR-only iciHHV-6B by partial excision of full-length iciHHV6-B genomes in the 375 
germline 376 
The frequency of truncations and new telomere formation at DRR-T1 in sperm DNA from 377 
iciHHV-6B carriers raised the strong possibility that such events could explain how individuals may 378 
inherit integrations consisting only of DR (DR-only iciHHV-6A/6B) (Huang et al., 2014; Liu et al., 2020; 379 
Ohye et al, 2014). To date, we have identified three individuals (308006 and SAL018 in the present 380 
study, and KEN071 (Huang et al., 2014)) who carry iciHHV-6B DR-only. Comparison of pvT1 repeat 381 
patterns in these samples with DRR-pvT1/DRL-pvT1 repeat patterns in full length iciHHV-6B 382 
suggested shared ancestry between these individuals with DR-only iciHHV-6B and those with full 383 
length iciHHV-6B (Figure 3A). To investigate this, attempts were made to amplify and sequence the 384 
subtelomere-iciHHV-6B junction, based on previously described junction fragments (Tweedy et al., 385 
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2016; Zhang et al., 2017) and using primers that anneal in the subtelomeric regions of various 386 
chromosomes (Figure 3B). Using this approach, we found that the DR-only iciHHV-6B in SAL018 and 387 
KEN071 share the common 17p (major) subtelomere-iciHHV-6B junction that is also found in 388 
801018, d44 and others (Figure 3C). Similarly, the pattern of telomere and degenerate repeats 389 
across a subtelomere-iciHHV-6B junction (amplified by subtelomere primer 2p2) in the DR-only 390 
iciHHV-6B sample 308006, closely matched those in full length iciHHV-6B individuals 401027 and 391 
410005 (Figure 3C). The existence of shared integration sites for the full-length and DR-only iciHHV-392 
6B carriers at two different chromosome ends clearly establishes that the DR-only status has arisen 393 
independently, on at least two occasions, by loss of U and one copy of DR in the germline of an 394 
ancestor with a full-length iciHHV-6B genome.  395 
 396 
Evidence of viral transmission from iciHHV-6B carrier mother to non-iciHHV-6B son  397 
It has been shown that iciHHV-6A can reactivate in an immune-compromised setting (Endo 398 
et al., 2014) and there is evidence of transplacental transmission of reactivated iciHHV-6A/6B 399 
(Gravel et al., 2013). Despite these examples, the high prevalence of HHV-6B in populations has 400 
made it difficult to determine how often iciHHV-6B reactivation occurs. The evidence for frequent 401 
partial or complete release of iciHHV-6B genomes in somatic cells and the germline presented above 402 
suggests that opportunities for reactivation may be more common than currently appreciated. To 403 
explore this, we used DRR-pvT1 analysis to investigate the relationship between strains of iciHHV-6B 404 
and low-level acqHHV-6B within families. In one family (Rx-F6a), the mother (G3P1) had a low 405 
acqHHV-6B load in saliva (0.00035 copies per cell), but both her children were iciHHV-6B carriers. 406 
The DRR-pvT1 repeat patterns in the children were identical and presumed to have been inherited 407 
from the father, who was not available for testing. Clearly the mother in this family had a different 408 
HHV-6B strain with a distinct DRR-pvT1 repeat pattern (Figure 7A, Figure 7- figure supplement 1). 409 
Quantification of HHV-6B in saliva samples from another family (Rx-F3a, Figure 7B) showed 410 
that the mother (G3P2) was an iciHHV-6B carrier and that her daughter (G4P3) had approximately 2 411 
copies of iciHHV-6B per cell. Identical DRR-pvT1 repeat patterns between the mother and daughter 412 
proved maternal inheritance of one iciHHV-6B copy. A second, distinct DRR-pvT1 repeat pattern in 413 
the daughter was assumed to represent iciHHV-6B inherited from the father, who was not available 414 
for testing. The son (G4P1) had 0.00025 copies of HHV-6B per cell in saliva DNA, consistent with the 415 
level expected from acqHHV-6B infection (Figure 7- figure supplement 1). Importantly, the DRR-pvT1 416 
repeat pattern in the son (G4P1) was identical to that in the mother and one copy of iciHHV-6B in his 417 
sister. This repeat pattern was not seen outside this family among 102 DRR-pvT1 repeat patterns 418 
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(Figure 1 – figure supplement 1). These observations strongly suggest that iciHHV-6B genome 419 
excision occurred in the mother and that the reactivated HHV-6B was then transmitted to the non-420 
iciHHV-6B son, who retained residual viral sequences in his saliva.  421 
 422 
Discussion 423 
The discovery of germline transmission of chromosomally-integrated HHV-6A/6B genomes 424 
has raised questions about the possible relationship between iciHHV-6A/6B carrier status and 425 
lifelong disease risk (Gravel et al., 2015) (Gaccioli et al., 2020; Hill et al., 2017). Events that could 426 
have deleterious consequences include full viral reactivation (Endo et al., 2014; Gravel et al., 2013; 427 
Hall et al., 2010), intermittent expression of iciHHV-6A/6B genes that may elicit intermittent immune 428 
and inflammatory responses over a lifetime (Peddu et al., 2019), and an impact on telomere stability 429 
and function (Huang et al., 2014; Prusty et al., 2013; Wood & Royle, 2017; Zhang et al., 2017).  430 
Progress towards understanding the potential impact of iciHHV-6A/6B carrier status has 431 
been advanced by the recent increase in the number of HHV-6A/6B genome sequences available 432 
(Aswad et al., 2021; Greninger et al., 2018; Zhang et al., 2017). This has shown that most iciHHV-433 
6A/6B genomes in populations are derived from a small number of ancient telomere-integration 434 
events. Here we have expanded the number of sequenced iciHHV-6A/6B genomes from individuals 435 
in Europe and North America and developed the web-based HHV-6 Explorer that can be used to 436 
interrogate diversity and functionality between inherited and acquired HHV-6A or HHV-6B genomes. 437 
The HHV-6 Explorer includes the sequence of 84 complete or nearly complete iciHHV-6A/6B 438 
genomes representative of the various known clades in the phylogenetic network and genome 439 
sequences from 28 HHV-6A/6B viruses circulating in populations. Using the HHV-6 Explorer we 440 
displayed two mutations that introduced stop codons in U79 in three of seven iciHHV-6A samples in 441 
the 17p clade and in U14 in one of three iciHHV-6B samples in the 17p (minor) clade (Figure 2 – 442 
figure supplement 1), demonstrating that each mutation arose after integration. The presence of an 443 
inactivating iciHHV-6A/6B mutation in some but not all descendants of a particular ancestral 444 
integration event adds a further complication to understanding the potential lifetime risk for 445 
individual iciHHV-6A/6B carriers.  446 
The relationship between iciHHV-6A/6B carrier status and potential associated disease risk 447 
may also be influenced by interactions between the integrated viral genome and genes or chromatin 448 
on the chromosome carrying the viral genome (Gravel et al., 2015; Wood & Royle, 2017). It is 449 
therefore important to have a rapid method to distinguish between viral strains and integration 450 
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sites, which is offered by the hypervariable pvT1 region in HHV-6B. pvT1 is a complex repeat region 451 
comprising a variety in degenerate repeats, variation in repeat number and the interspersed nature 452 
of different repeats. Nevertheless, pvT1 length variation is mostly attributable to the diverse 453 
interspersion of (CTAGGG) and canonical (TTAGGG) telomere repeat sequences in the central region 454 
of pvT1 amplicons. Notably, short blocks of (CTAGGG)n repeats are highly unstable in human 455 
telomeres in somatic and germline cells, probably due to replication errors and in vitro studies 456 
showed that (CTAGGG)n repeats bind efficiently to POT1, a component of Shelterin (Barrientos et al, 457 
2008; Baumann & Cech, 2001; de Lange, 2018; Lim et al, 2009; Loayza et al, 2004; Mendez-458 
Bermudez et al, 2009). Furthermore, pvT1 in iciHHV-6B and acqHHV-6B will mutate at different rates 459 
and have interconnected but different evolutionary histories, influenced by viral genome integration 460 
and excision rates that are currently unknown. Consequently, comparative analysis of the DRR-pvT1 461 
repeat patterns was achieved manually by dividing the pattern of repeats into the proximal, central 462 
and distal regions with respect to the DR421 primer. Where possible, distinctive motifs that 463 
distinguish between the pvT1 repeat patterns of various ciHHV-6B clades were identified 464 
(Supplementary File 3) and these were informed by known relationships between iciHHV-6B 465 
genomes based on whole genome sequence similarity, subtelomere-iciHHV-6B junctions, and FISH. 466 
Furthermore, the presence of a particular motif in DRR-pvT1 and DRL-pvT1 in a single iciHHV-6B 467 
genome indicated that the pattern was present at integration, and this was a useful aid to defining 468 
the pvT1 repeat pattern for the clade. As pvT1 repeat patterns from additional samples with known 469 
phylogenetic relationships become available an automated analysis of pvT1 is desirable. 470 
Nevertheless, from the data presented it is clear that DRR-pvT1 repeat patterns can be used in many 471 
cases as a rapid and inexpensive way to predict the phylogenetic clade and integration site of an 472 
iciHHV-6B genome.  473 
DRR-pvT1 analysis is also an excellent tool for tracking acqHHV-6B transmission in families as 474 
shown by the evidence that community-acquired HHV-6 transmission usually occurs between family 475 
members, with maternal transmission most common. We showed that DRR-pvT1 repeat patterns can 476 
be used effectively to discriminate between HHV-6B strains circulating in communities (61/63 477 
different DRR-pvT1 sequences in saliva from healthy non-iciHHV-6B donors in the UK). In the future, 478 
DRR-pvT1 analysis could be used to trace patterns of transmission more generally. This may be 479 
particularly important in the setting of organ and tissue transplants (Hill, 2019). For example, 480 
reactivation of iciHHV-6B from a donor tissue could be monitored and differentiated from HHV-6B 481 
acquired by the recipient in early childhood or to identify cases of multiple infections by different 482 
strains of HHV-6B.  483 
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The iciHHV-6B and free HHV-6B viruses in communities must have evolutionary histories 484 
that are interlaced but these are difficult to disentangle as there is little understanding of HHV-6 485 
telomeric integration and iciHHV-6B excision and reactivation. The current picture indicates a 486 
modest number of ancient iciHHV-6B clades (in Europe and North America at least) some of which 487 
are accumulating mutations that could prevent full reactivation (discussed above). There is also at 488 
least one example of an iciHHV-6B genome with high sequence homology to a group of genome 489 
sequences from acqHHV-6B (Aswad et al., 2021; Greninger et al., 2018), which complicates 490 
interpretation of HHV-6B phylogenetic relationships (Forni et al, 2020). Indirectly this suggests that 491 
some modern circulating strains retain the capacity for germline integration into telomeres and 492 
inheritance or that iciHHV-6B can reactivate and be transmitted, re-entering the reservoir of 493 
circulating strains. We demonstrated that some copies of HHV-6B in saliva acquire a telomere, 494 
indicative of integration in somatic cells in vivo and as previously detected in vitro (Arbuckle et al., 495 
2010). The viral load in the saliva samples was low, as seen in some other studies (Leibovitch et al, 496 
2014; Leibovitch et al, 2019; Turriziani et al, 2014), and the number of HHV-6B genomes with a 497 
telomere was small (Figure 4, Supplementary File 4), which is consistent with the majority of HHV-6B 498 
genomes present as viral particles in saliva (Jarrett et al, 1990). The approach we used to detect 499 
telomeric integration in saliva could, in principle, be used to detect HHV-6B integration events in 500 
sperm from healthy non-iciHHV-6B men (Neofytou et al, 2009) (Godet et al, 2015; Kaspersen et al, 501 
2012). This would address the outstanding question of whether current HHV-6B strains circulating in 502 
communities can integrate in the germline.  503 
Previously we have proposed that iciHHV6A/6B genomes can be excised from telomeres in a 504 
one or two-step process as by-products of t-loop processing (Huang et al., 2014; Wood & Royle, 505 
2017). In this study we measured the frequency of iciHHV-6B excision events, by detection of novel 506 
telomeres at DRL-T2 and for the first time at DRR-T1, in unrelated iciHHV-6B carriers and in different 507 
tissues and cell types. The frequencies of iciHHV-6B truncations at DRL-T2 (range, 0.014 - 0.0031 per 508 
cell) and DRR-T1 (range, 0.0002-0.0029 per cell) are not directly comparable because they were 509 
ascertained by different approaches that have different efficiencies, but both are surprisingly high in 510 
vivo (Figure 5, Figure 6). This demonstrates that tissues in iciHHV-6B carriers must be mosaic for 511 
different compositions of the iciHHV-6B genome. The telomeres formed at DRL-T2 were expected to 512 
be particularly short, limited to the length of the (TTAGGG) repeat array at T2. However, a cell with a 513 
small number of very short telomeres will elicit a telomere-mediated DNA damage response and 514 
entry into cellular senescence (Cesare et al, 2013; d'Adda di Fagagna et al, 2003; de Lange, 2018; 515 
Takai et al, 2003) so preventing proliferation of a cell with a potentially unstable residual iciHHV-6B 516 
genome. It is therefore remarkable that a high percentage of newly formed telomeres at DRL-T2 517 
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were lengthened. The frequency of DRL-T2 telomere lengthening was highest in circulating white 518 
blood cells and in two pluripotent cell lines (Figure 5) consistent with lengthening by telomerase. 519 
From these observations and the increase in viral genome excision events in TSA treated cells, we 520 
also propose that iciHHV-6A/6B genomes are more likely to be excised and reactivated in 521 
undifferentiated or pluripotent cells. By extrapolation, the potential for iciHHV-6A/6B genome 522 
excision, viral gene expression or full reactivation has the potential to be deleterious during early 523 
development (Miura et al., 2020). 524 
Finally, we present two lines of evidence that iciHHV-6B genome can be excised and re-enter 525 
the reservoir of circulating HHV-6B strains. First, we identified individuals with full-length iciHHV-6B 526 
or DR-only genomes that fall into the same clade in the phylogenetic tree (Figure 3). These 527 
integrated full-length iciHHV-6B or DR-only genomes share similar pvT1 repeat patterns and 528 
subterminal-iciHHV-6B junction sequences. This demonstrates that the different iciHHV-6B 529 
structures are carried in the same telomere-allele at the particular chromosome end and it proves 530 
that these DR-only carriers have arisen by germline excision of U-DR in an ancestor. The fact that this 531 
has occurred independently at least twice suggests this is a relatively common event, and this is 532 
supported by our evidence that new telomere formation at DRR-T1 occurs at a measurable 533 
frequency in sperm DNA. Second, we show an example of probable reactivation of iciHHV-6B in a 534 
mother with transmission to her son, who carries a very low load of acqHHV-6B with the same 535 
distinctive DRR-pvT1 repeat pattern in his saliva. This observation warrants further research to 536 
determine how frequently HHV-6B is transmitted from iciHHV-6B parent to their non-iciHHV-6B 537 
children but it requires the use of a hypervariable marker, such as pvT1, that has the power to 538 
discriminate between HHV-6B strains.  539 
 540 
Materials and Methods  541 
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Saliva collection and DNA extraction  544 
The study was conducted in accordance with the Declaration of Helsinki and with the approval of the 545 
University of Leicester’s Research Ethics Committee (refs: 10553-njr-genetics; njr-61d3). Saliva 546 
samples were donated by individuals and members of families (all 18 years or older) with informed 547 
consent and were given anonymous identifiers at the point of collection (Garrido-Navas et al, 2020). 548 
Approximately 1.5 ml of saliva was collected in a OraGEN saliva collection tube (Genotek, Ottawa, 549 
Canada), and DNA was extracted from 500 µl following the manufacturer’s instructions.  550 
 551 
Identification of DNA samples and cell lines with iciHHV-6A/6B or acqHHV-6B 552 
The full list of iciHHV-6A/6B-positive DNA samples and cell lines used in this study is given in 553 
Supplementary File 1 with available information on donor ethnicity and iciHHV-6A/6B chromosomal 554 
location. To interrogate any relationship between iciHHV-6A/6B carrier status and heart failure, the 555 
BIOlogy Study to TAilored Treatment in Chronic Heart Failure (BIOSTAT-CHF) cohort (Voors et al, 556 
2016) was screened. The BIOSTAT-CHF study complied with the Declaration of Helsinki and was 557 
approved by the relevant ethics committee in each centre, while all participants gave their written, 558 
informed consent to participate. The 2470 blood DNAs from Europeans in the BIOSTAT-CHF cohort 559 
was screened using PCR assays to detect the viral genome (multiplexed PCR to detect HHV-6A/6B 560 
DR3 and human MS32 flanking sequence, as a positive control). Positive samples were rescreened 561 
with PCR assays to detect DR5 for HHV-6A, DR6 for HHV-6B and U18 to detect the unique region 562 
(Huang et al., 2014; Zhang et al., 2017). This identified 19 iciHHV-6A/6B positive samples (nine 563 
iciHHV-6A, 0.36%, and ten iciHHV-6B, 0.40%, one of which was iciHHV-6B DR-only). Five iciHHV-6B 564 
carriers were identified among the saliva donors: three with a single copy of iciHHV-6B, one with two 565 
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copies of iciHHV-6B, and one with iciHHV-6B DR-only. The saliva samples were also screened for 566 
acqHHV-6B using ddPCR, described below. Additionally, two kidney DNA samples (part of the 567 
TRANScriptome of renaL humAn TissuE (TRANSLATE) study (Marques et al, 2015; Rowland et al, 568 
2019)) were positive for DR3 by PCR assay and were confirmed as acqHHV-6B by ddPCR. 569 
 570 
HHV-6B quantification by ddPCR 571 
HHV-6B copy number was estimated by duplexed HHV-6B POL (U38) vs RPP30 (human gene, two 572 
copies per diploid cell) ddPCR assays as describe previously (Bell et al, 2014). Hydrolysis probe 573 
ddPCRs (20 l volumes) consisted of 1 x ddPCR Supermix for probes without dUTP (Bio-Rad 574 
Laboratories), virus-specific primers (HHV-6B POL F and HHV-6B POL R) and FAM-labelled HHV-6B 575 
POL (U38) probe (Eurogentec; Supplementary File 7) at 300 nM and 200 nM respectively, 1 x RPP30 576 
primer/HEX labelled probe mix (Bio-Rad Laboratories), 1 l  XhoI digestion mix consisting of 5U XhoI 577 
restriction enzyme and 1 x NEB buffer 2.1 (New England Biolabs), and 10 ng genomic DNA for 578 
iciHHV-6B samples or 200 ng DNA for non-iciHHV-6B samples. Droplets were generated using QX200 579 
Droplet Generator (Bio-Rad Laboratories) with 70 l Droplet Generation Oil for Probes (Bio-Rad 580 
Laboratories). Thermocycling was carried out according to the manufacturer’s instructions on a 581 
Veriti 96-well Thermal Cylcer (Applied Biosystems) as follows: 95°C, 10 m; 40 cycles 94°C 30 s, 60°C 1 582 
m; 98°C 10 m. QX200 Droplet Reader and QuantaSoft analysis software (Bio-Rad Laboratories) were 583 
used to count droplets and measure fluorescence, and to calculate the estimated copy number. DNA 584 
from the HT1080, an osteosarcoma-derived established cell line that lacks HHV-6A/B DNA, and DNA 585 
from 6-iciHHV-6B, a cell line with one copy of iciHHV-6B, were used as a negative and positive 586 
controls respectively, alongside water no-template control reactions, when optimising the assays. 587 
Subsequently, reactions with HT1080 DNA or water were included in each ddPCR run, as a negative 588 
controls to detect non-specific amplification or contamination. Assays to quantify acqHHV-6B in DNA 589 
samples from saliva and kidney were carried out in triplicate to increase the accuracy of the copy 590 
number estimates. In addition, as very low viral copy number were expected in the non iciHHV-6B 591 
samples, the ddPCR reactions were set up in a PCR-clean room where no HHV-6 PCR had been 592 
conducted previously.  593 
As required, the copy number and basic organisation of the HHV-6B genome in iciHHV-6B samples 594 
was established using HHV-6B POL (U38), HHV-6B DR and RPP30 (human gene, two copies per 595 
diploid cell) hydrolysis-probe ddPCR assays describe above and previously (Bell et al., 2014).  Duplex 596 
ddPCRs of HHV-6B POL (U38) with RPP30 or DR6B (FAM-labelled DR6B probe, Eurogentec) with 597 
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RPP30 determined the copy number of each region and subsequent comparison established the 598 
iciHHV-6B genome composition (e.g. U1DR2 or DR-only) iciHHV-6B.  599 
Absolute quantification of DR and PAC1 was also determined by ddPCR but using the DNA 600 
intercalating dye, EvaGreen. Given the short length of the PAC1 amplicon, the cycle number, 601 
extension time and DNA input level were optimised to maximise the resolution between the 602 
fluorescence level of positive and negative droplets. Subsequently the assays were conducted as 603 
follows: EvaGreen ddPCRs (20 l volumes) consisted of 1 x ddPCR EvaGreen Supermix (Bio-Rad 604 
Laboratories), virus-specific primers for DR (DR6B-F and DR6B-R) or PAC1 (PAC1F and PAC1R-33) at 605 
300 nM, 1 l XhoI digestion mix consisting of 5U XhoI restriction enzyme and 1 x NEB buffer 2.1 606 
(New England Biolabs, Ipswich, Massachusetts), and 10 ng genomic DNA for iciHHV-6B samples or 607 
100 ng DNA for non-iciHHV-6B samples. Droplets were generated using QX200 Droplet Generator 608 
(Bio-Rad Laboratories) with 70 l Droplet Generation Oil for Evagreen reactions (Bio-Rad 609 
Laboratories). Thermocycling was carried out on a Veriti 96-well Thermal Cycler (Applied Biosystems) 610 
with the following conditions: 95°C, 5 m; 45 cycles of 94°C 30 s, 60°C 1 m; 4°C 5 m; 90°C 5 m. QX200 611 
Droplet Reader and QuantaSoft analysis software (Bio-Rad Laboratories) were used to count 612 
droplets and to calculate absolute copy number of each amplicon per µl of each reaction. 613 
 614 
Cell culture and TSA treatment 615 
LCLs with iciHHV-6B were cultured in RPMI 1640 medium as described previously (Huang et al., 616 
2014). The CRL-1730 (RRID:CVCL_2959) adherent human vascular endothelial cell line derived from 617 
umbilical cord vein (ATCC, (Shioda et al., 2018)) was cultured in F-12K medium (Gibco/ThermoFisher 618 
Scientific) supplemented with 10% heat inactivated foetal bovine serum (Gibco/ThermoFisher 619 
Scientific), 0.1 mg/ml heparin (Sigma-Aldrich, Darmstadt, Germany) and 1% endothelial growth 620 
supplement (BD Biosciences). The adherent mesenchymal stem cell line derived by explant culture 621 
from umblical cord, d37 (gifted by Dr Sukhvir Rai, University of Leicester), was cultured in human 622 
mesenchymal stem cell growth media (MSCBM hMSC Basal Medium, Lonza, Basel, Switzerland) 623 
supplemented with mesenchymal stem cell growth supplements (MSCGM hMSC SingleQuot Kit, 624 
Lonza, Basel, Switzerland).  625 
For TSA treatment, 2 x 106 cells from the 4B-11p15.5 iciHHV-6B LCL were suspended in RPMI 1640 626 
medium supplemented with 0, 100 or 200 ng/ml Trichostatin A (Sigma-Aldrich, Darmstadt, Germany) 627 
in three biological replicates. After 124 h (5 days), cells were pelleted at 1200 rpm for 8 min, washed 628 
twice with phosphate-buffered saline and snap-frozen on dry ice. DNA was extracted using phenol-629 
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chloroform and precipitated using ethanol. The DNA pellet was washed with 80% ethanol, briefly air-630 
dried and dissolved in nuclease-free water. DRL-T2 STELA (see below) was conducted on extracted 631 
DNA using primer UDL6R to detect telomeres at DRL-T2, as described previously (Huang et al.). STELA 632 
was carried out twice on DNA from each treatment from each of three biological replicates. 633 
 634 
Whole iciHHV-6A/6B genome sequencing 635 
Ten iciHHV-6A and five iciHHV-6B genomes were sequenced and annotated as described previously 636 
(Huang et al., 2014; Zhang et al., 2017). Pooled, overlapping PCR amplicons (100 ng) were sheared 637 
using a Covaris S220 sonicator to an approximate size of 450 bp. Sequencing libraries were prepared 638 
using the LTP library preparation kit for Illumina platforms (Kapa Biosystems, Germany). The libraries 639 
were then processed for PCR (7 cycles) using the LTP library preparation kit and employing NEBNext 640 
multiplex oligos for Illumina index primer pairs set 1 (New England Biolabs, Ipswich, Massachusetts). 641 
Sequencing was performed using a NextSeq 500/550 mid-output v2.5 300 cycle cartridge (Illumina, 642 
San Diego, California) to produce 6-9 million paired-end 150 base reads per sample. The annotated 643 
sequences were deposited in NCBI GenBank under accession numbers: MW049313-MW049327. 644 
 645 
Genome sequence analysis 646 
94 complete or near-complete HHV-6A/6B sequences were downloaded from NCBI GenBank 647 
(Supplementary File 1) and, together with the 15 newly sequenced genomes, were aligned using 648 
MAFFT (v7.407, (Katoh & Standley, 2013)) with default parameters. The alignment was trimmed 649 
using trimAI (v1.4.1, (Capella-Gutierrez et al, 2009)) to remove gaps. Phylogenetic networks were 650 
inferred using FastME (v2.1.6.1), a distance-based algorithm, with bootstrap values calculated from 651 
100 replicates. Phylogenetic networks were plotted using Interactive Tree of Life browser application 652 
(https://itol.embl.de, v6.1) (Letunic & Bork, 2016). The time to the most recent common ancestor 653 
was estimated using Network 10.0 (Fluxus-engineering, Colchester, United Kingdom) using rho 654 
values calculated by Network (Forster et al, 1996) and an assumed mutation rate of 0.5 x 10-9 655 
substitutions per base per year (Scally & Durbin, 2012; Zhang et al., 2017).  656 
 657 
Development of the HHV-6 explorer  658 
The HHV-6 Counter takes a fasta multiple alignment and compares each sequence to a selected 659 
reference HHV-6 strain to generate counts of genetic variation (substitutions, insertions, deletions) 660 
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from overlapping or non-overlapping windows across the HHV-6 genome. If a corresponding 661 
genbank file for the reference is present, HHV-6 Counter will also provide windowed counts for 662 
coding sequence and amino acid variation across the genome and for each gene. This includes 663 
missense/nonsense changes, in-frame insertions/deletions, nonsense insertions, potential splice site 664 
changes, loss of start or stop and tracking of frameshift changes. Windows which contain non-665 
standard base characters or have sequence gaps due to method failures are flagged but their counts 666 
are still retained in the results. HHV-6 Counter exports the count windows both as a series of Excel 667 
files and as a python panda pickle file for use in the HHV-6 Explorer.  668 
The HHV-6 Explorer is based on plotly Dash (https://dash.plotly.com/) and, using the output from 669 
HHV-6 Counter, allows the graphical display of variation counts for different strains across the HHV-6 670 
genomes and/or on a per gene basis compared against a selected reference HHV-6 strain. It also 671 
displays a multiple alignment for the selected gene. A pre-populated version of HHV-6 Explorer 672 
containing the data from this manuscript can be found at https://www.hhv6explorer.org/ . The 673 
source code for HHV-6 Explorer and HHV-6 Counter is available from 674 
https://github.com/colinveal/HHV6-Explorer. 675 
 676 
PCR primers and other oligonucleotides. 677 
The sequences of primers and hydrolysis probes used in the study are listed in Supplementary File 7. 678 
 679 
Amplification and analysis of subtelomere-iciHHV-6B junctions 680 
Subtelomere-iciHHV-6B junctions were amplified by PCR (33 cycles) using a trial and error approach 681 
with primer DR8F(A/B) and various primers known to anneal to chromosomal subtelomere regions  682 
(Zhang et al., 2017). Amplicons were purified using a Zymoclean gel DNA recovery kit (Zymo 683 
Research, Irvine, California) and sequenced using primer DR8FT2 or the appropriate subtelomere 684 
primer (Supplementary File 7). The number and pattern of telomere repeats (TTAGGG) and 685 
degenerate telomere-like repeats across the subtelomere-iciHHV-6B junction amplicons were 686 
identified and colour-coded manually to generate repeat patterns. 687 
 688 
Amplification and analysis of HHV-6B DRR-pvT1 and DRL-pvT1 689 
DRR-pvT1 was amplified by PCR using primers DR1R and U100Fw2 in the first round (94°C, 1.5 min; 690 
25 cycles 94°C 15 s, 62°C 30 s, 68°C 10 min; 68°C 2 min) and primers DR421R and TJ1F in the second 691 
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round (94°C, 1.5 min; 25 cycles 94°C 15 s, 64°C 30 s, 68°C 1.5 min; 68°C 2 min). DRL-pvT1 was 692 
amplified by STELA (see below) followed by a secondary PCR using primers DR421R and TJ1F. The 693 
short pvT1 amplicons were size-separated by electrophoresis in a 3% NuSieve (Lonza, Basel, 694 
Switzerland) agarose gel, extracted and Sanger sequenced using primer TJ1F. The number and 695 
pattern of (TTAGGG) and degenerate telomere-like repeats were identified and colour-coded 696 
manually to generate pvT1 repeat patterns. For comparative analysis the DRR-pvT1 repeat patterns 697 
were aligned manual by dividing them in to the proximal, central and distal regions with respect to 698 
the DR421 primer and distinctive motifs identified (Supplementary File 3).  699 
 700 
STELA and detection of newly formed telomeres at DRR-T1 and DRL-T2 701 
The telomere at the end of the iciHHV-6B genome was amplified by STELA using the DR1R primer 702 
and Telorette 2/Teltail essentially as described previously (Huang et al., 2014; Jeyapalan et al., 2008). 703 
DNA was diluted to 250-1000 pg/µl for cell line DNA, 500 pg/µl for saliva DNA, 600 pg/µl for blood 704 
DNA and 1000 pg/µl for sperm DNA. The primer concentrations in each 10 µl STELA reaction were 705 
0.3 µM DR1R, 0.225 µM Telorette2 and 0.05 µM Teltail. Taq polymerase (Kapa Biosystems, 706 
Germany) was used at 0.04 U/µl and Pwo (Genaxxon Bioscience, Ulm, Germany) at 0.025 U/µl. The 707 
STELA PCRs were cycled 25 times. 708 
To detect telomeres at DRR-T1, STELA was conducted as above using primers DR1R and Telorette 709 
2/Teltail on iciHHV-6B DNA samples that showed a length difference between DRL-pvT1 and DRR-710 
pvT1. Next the STELA reaction product (1 µl) was diluted 1:10 in water and used as input for PCR of 711 
pvT1 using primers DR421R and TJ1F (cycling conditions as above, 25 cycles). The amplicons were 712 
size-separated by agarose gel electrophoresis to distinguish DRR-T1-associated telomeres from the 713 
majority of DRL-T1-associated telomeres. The remainder of the undiluted STELA product was size-714 
separated by agarose gel electrophoresis and amplified telomeres detected by Southern blot 715 
hybridisation to a radiolabelled (TTAGGG)n probe. 716 
To detect telomeres at DRL-T2, primer UDL6R was used in STELA reactions instead of primer DR1R 717 
with 250-1000 pg genomic DNA per reaction and cycled 26 times (Huang et al., 2014). Amplicons 718 
hybridising to the radiolabelled (TTAGGG)n probe that migrated at less than 900 bp were counted as 719 
unlengthened truncations, those between 900 bp and 8.6 kb were counted as lengthened 720 
truncations, and those larger than 8.6 kb were not counted as truncations. The number of 721 
truncations per cell was estimated by converting the amount of input DNA to cell equivalents on the 722 
assumption that a cell contains 6.6 pg DNA (or 3.3 pg for a haploid sperm cell) and dividing the 723 
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number of truncations (lengthened and unlengthened) by the number of cells screened. To 724 
sequence DRL-T2-associated telomeres, STELA products were extracted from agarose gel slices using 725 
repeated freeze-thawing and reamplified using primers DR8RT2 and Telorette 2. The recovered 726 
amplicons were Sanger sequenced. 727 
 728 
Detection of integrated HHV-6B in individuals with acqHHV-6B 729 
STELA was carried out on genomic DNA from individuals with a known copy number of acqHHV-6B, 730 
measured by ddPCR. As the copy number of acqHHV-6B was low and telomere integration events 731 
expected to be lower, various precautions were introduced for these experiments. STELA reactions 732 
were set up in a room previously unused for any STELA or HHV-6 experiments. In addition to avoid 733 
contamination with previously generated iciHHV-6A/6B STELA products, STELA primers with new 734 
barcodes (Telorette2BC28/Teltail2BC38) and a new a flanking primer (DR2RSTELA) were used. The 735 
DR2RSTELA primer anneals upstream of the DR1R primer used for other iciHHV-6A/6B STELA 736 
reactions so preventing amplification of any previously generated STELA amplicons. STELA reactions 737 
were set up as above, but as the acqHHV-6B copy number was low in these samples, the quantity of 738 
genomic DNA added was increase to 2-5 ng per reaction and cycled 25 times as above. To test that 739 
the higher DNA input did not inhibit the potential to amplify an HHV-6B associated telomere (if 740 
present) optimisation experiments were undertaken. These included dilution of genomic DNA from 741 
an iciHHV-6B cell line (one copy per cell) with increasing quantities (0, 100, 500, 1000 and 5000 pg 742 
per PCR) of DNA from the HT1080 cell line (HHV-6A/6B negative) followed by STELA in multiple 743 
parallel reactions.  This showed that neither the number of HHV-6-associated telomeres amplified by 744 
STELA, nor the average length, was affected in the presence of increasing quantities of human 745 
genomic DNA (up to 5 ng per reaction).  746 
Following completion of the multiple parallel STELA reactions, 1 µl of each reaction was diluted 1:10 747 
in water and used as input for amplification of DRL-pvT1, using primers DR421R and TJ1F (cycling 748 
conditions as above, 25 cycles). The amplicons were sequenced using TJ1F to confirm that the DRL-749 
pvT1 sequence in the amplified telomere was the same HHV-6B strain as present in that saliva 750 
sample. The remainder of the undiluted STELA product was size-separated by agarose gel 751 
electrophoresis and detected by Southern blot hybridisation to a radiolabelled (TTAGGG)n probe. As 752 
a control for non-specific amplification from another telomere or elsewhere in the human genome, 753 
900 STELA reactions were conducted each with 5 ng genomic DNA from an HHV-6A/6B free cell line, 754 
HT1080 (4500 ng total). No STELA amplicons were generated from the HT1080 control reactions. 755 
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 756 
DR circles 757 
Double restriction digests were carried out at 37C for 1 hour using 10 U of each enzyme (XbaI and 758 
ScaI-HF, or PstI and SacI) and 1x NEB CutSmart Buffer (New England Biolabs, Ipswich, Massachusetts) 759 
in 500 uL reactions containing 10 g 4B-11p15.5 or 1B-HHV-6B DNA. Enzymes were heat inactivated 760 
at 80C for 20 minutes. Control DNA was treated without any restriction enzymes. Diluted DNA was 761 
amplified using PCR with primers DR8F(A/B) and DR3R with a 10 minute extension time (26 cycles). 762 
PCR products were size-separated on a 0.8% agarose gel with electrophoresis and amplicons were 763 
detected by Southern blot hybridisation to a radiolabelled telomere (TTAGGG)n probe. 764 
 765 
Statistical analysis 766 
Data are expressed as means ± standard error of the mean (SEM). Mann-Whitney test was used to 767 
compare unpaired groups of ranked data obtained from assays conducted on DNA derived from the 768 
same biological sample type (Figure 4C, 4F). The Wilcoxon test was used to compare paired groups 769 
of data obtained from treated and untreated samples. Statistical analyses were performed using 770 
Prism software (Version 9.0, Graphpad Software). Outliers were not removed from data sets. 771 
Samples sizes were based on availability of suitable biological materials. 772 
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Figure legends 1123 
Figure 1. Characterisation of the highly variable DRR-pvT1 in iciHHV-6B and acqHHV-6B genomes. (A) 1124 
Diagram showing the locations of PCR primers used to amplify the DRR-T1 region specifically 1125 
(U100Fw2 and DR1R) and the nested primers used to reamplify and sequence pvT1 (DR421R and 1126 
TJ1F) in the iciHHV-6B genome (left) and in the acqHHV-6B genome (right). (B) DRR-pvT1 repeat 1127 
patterns are shown to demonstrate diversity among a subset of iciHHV-6B (inherited) and acqHHV-1128 
6B (acquired) genomes from various individuals. Telomere-like and degenerate repeats present in 1129 
the HHV-6B pvT1 region are colour-coded as shown in the key and as follows: Dark green, TTAGGG; 1130 
cyan, TTAGTG; yellow, TTACTG; lime green, TTATGG; brown, CTAGGG; pink, CTATGG; dark yellow, 1131 
ATAGAC; teal, CTAAGG; blue, GTAGTG; peach, TTAGAG; red, GTCTGG. Black squares represent other 1132 
less common degenerate repeats, white squares show where the sequence could not be determined 1133 
accurately. Dashes between repeats were added to maximize alignment and to allow comparison 1134 
between the sections of DRR-pvT1, labelled proximal, central (highly variable) and distal (highly 1135 
conserved) with respect to the location of the DR421R primer. (C) DRR-pvT1 repeat patterns from 1136 
acqHHV-6B in two families. None of the family members were iciHHV-6 carriers. In both families the 1137 
HHV-6B DRR-pvT1 region in the two children was the same as one parent, indicating the children 1138 
carried the same strain of the virus, whereas the second parent carried a different strain. Blue 1139 
shapes indicate that the child had acqHHV-6B with the same pvT1 repeat map as the mother. 1140 
Analysis of DRR-pvT1 in the CEPH1375 family showed stable inheritance of the same pvT1 repeat 1141 
pattern across three generations. iciHHV-6B carriers in the CEPH1375 family are shown as filled black 1142 
symbols 1143 
 1144 
Figure 2. Distance-based phylogenetic networks for HHV-6A and HHV-6B. (A) A phylogenetic 1145 
network of 41 HHV-6A viral genome sequences. High sequence homology to iciHHV-6A genomes for 1146 
which the integration site had already been established allowed all but one (GLA_4298) iciHHV-6A 1147 
genomes to be assigned to a telomeric integration site. The colours indicate a chromosomal 1148 
integration as follows: Green, 19q; Orange, 18q; Purple, 10q; Yellow-green, 22q; Blue, 17p. The 1149 
name in black identifies the iciHHV-6A strain without a predicted chromosomal location. Non-1150 
inherited, acqHHV-6A strains are shown in red. iciHHV-6A genomes sequenced as part of this study 1151 
are identified by a black asterisk.  (B) A phylogenetic tree of 68 HHV-6B genome sequences (51 1152 
iciHHV-6B and 17 acqHHV-6B). iciHHV-6B genomes sequenced as part of this study are identified by 1153 
a black asterisk. High sequence homology to iciHHV-6B genomes with a known integration site 1154 
(already established by FISH) allowed the majority of iciHHV-6B genomes to be assigned a telomeric 1155 
chromosomal location. From the newly sequenced iciHHV-6B genomes two new clades were 1156 
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identified and provisionally labelled as: 17p (minor) and 2p. The 17p (minor) clade includes the 1B-1157 
iciHHV-6B genome, previously a singleton in HHV-6B networks, and the iciHHV-6B genomes in 1158 
704021 and 704016. The subtelomere-iciHHV-6B junction sequences, amplified with the 17p311 and 1159 
DR8F(A/B) primers, are similar for all three samples and distinct form the 17p (major) clade. The 1160 
other new clade is characterised by the iciHHV-6B genome (401027). This group is provisionally 1161 
labelled 2p because the subtelomere-iciHHV-6B junction was amplified by the 2p2 and DR8F(A/B) 1162 
primers in 401027, and two other samples (410005 and 308006, see Figure 3C).  1163 
 1164 
Figure 3. pvT1 repeat patterns are similar between strains of iciHHV-6B known to have the same 1165 
ancestral integration site and those predicted to share that integration site. (A) Distance-based 1166 
phylogenetic tree of selected iciHHV-6B (black names) and acquired HHV-6B (red names) genomes. 1167 
Where DNA was available, DRR-pvT1 repeat patterns from 19 iciHHV-6B samples in the phylogenetic 1168 
tree are shown. The repeats in the pvT1 region are colour-coded as for Figure 1 and shown in the 1169 
key, top right. Black vertical bars on the right indicate groups of iciHHV-6Bs for which the integration 1170 
site has been determined by FISH, phylogeny, subtelomere-iciHHV-6B junction analysis or a 1171 
combination of these. In addition, red asterisks identify samples from the 9q-iciHHV-6B clade that 1172 
share identical pvT1 repeat patterns. pvT1 repeat patterns are more variable between samples that 1173 
belong to the 17p (major) iciHHV-6B clade with black asterisks identifying samples that share 1174 
identical pvT1 patterns. DRR-pvT1 repeat patterns within black boxes identify iciHHV-6B samples for 1175 
which the integration site has been predicted based on DRR-pvT1 similarity. For some of these 1176 
samples the integration site has been validated by subtelomere-iciHHV-6B junction analysis (410005, 1177 
308006, d44, SAL018, NWA008 and KEN071).  (B) Line diagram showing the position of DR8F(A/B) 1178 
and potential subtelomere primers used to amplify and sequence subtelomere-iciHHV-6B junctions. 1179 
The subtelomere-iciHHV-6B integration site can be amplified whether the integrated viral genome is 1180 
full length or iciHHV-6B-DR only. (C) Diagram showing of the pattern of canonical (TTAGGG) and 1181 
degenerate telomere-like repeat maps across the subtelomere-HHV-6B junction at two different 1182 
chromosome ends. The subtelomere-HHV-6B repeat maps from the 401027, 410005 and 308006 1183 
were generated following amplification with primers 2p2 and DR8F(A/B). They are very similar 1184 
demonstrating common ancestry (top three repeat maps). The subtelomere-HHV-6B repeat maps 1185 
from the 801018, d44, SAL018 and KEN071 generated by amplification with 17p311 and DR8F(A/B) 1186 
(bottom four maps) are very similar to the group of iciHHV-6B genomes in the 17p (major) clade 1187 
some of which have been shown to be integrated in 17p. The 308006, SAL018 and KEN071 samples 1188 
contain iciHHV-6B DR-only. The key (bottom right) shows the colour-coding for the diverse 1189 
degenerate repeats found across the subtelomere-HHV-6B repeat maps. 1190 
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 1191 
Figure 4. Evidence of telomere formation at the distal end of HHV-6B genomes in individuals with 1192 
community-acquired HHV-6B. (A) Graph showing HHV-6B copy number per cell estimated from HHV-1193 
6B POL (U38) vs  RPP30 duplex ddPCR. Triplicate results are shown for saliva DNA from 52 individuals 1194 
and kidney samples from two individuals. Crosses show where zero copies per cell were estimated 1195 
for a single replicate and black crosses indicate that zero copies per cell were estimated from all 1196 
three replicates. The mean and standard error are shown. (B) STELA primers, DR2RSTELA and 1197 
Telorette2BC38/TeltailBC38, that were used to amplify HHV-6B associated telomeres are shown on 1198 
an integrated HHV-6B genome. DR421R and TJ1F primers were used to amplify DRL-pvT1 in 1199 
secondary nested PCRs. In non-integrated HHV-6B STELA products cannot be generated as there is 1200 
no HHV-6B-associated telomere. The copies of PAC1 (P1) and PAC2 (P2) are shown. (C) Examples of 1201 
HHV-6 STELA from two DNA samples (SAL039 and K10) with acqHHV-6B. Upper panels show the 1202 
outcome of 30 STELA reactions followed by agarose gel electrophoresis and Southern blot 1203 
hybridization to radiolabeled (TTAGGG)n telomere-repeat probe. In a small number of reactions an 1204 
amplified HHV-6B-associated telomere band was detected. An aliquot of the products from each 1205 
primary STELA PCR was diluted and used as input for a secondary, nested PCR to amplify DRL-pvT1. 1206 
As shown in the agarose gel photograph below, DRL-pvT1 positive reactions corresponded to the 1207 
STELA reactions that generated HHV-6B-associated telomere band. The 6-iciHHV-6B DNA was used 1208 
as a positive control (+) for STELA and DRL-pvT1 secondary PCR. (D) Graph showing the total copy 1209 
number of HHV-6B per cell measured by ddPCR (filled diamonds); the estimated number of copies of 1210 
integrated HHV-6B per cell from STELA and pvT1 PCR (open circles). (E) Measuring the DR:PAC1 ratio 1211 
by ddPCR. 1D EvaGreen ddPCR plots of one iciHHV-6B (4B-11p15.5) cell line and acqHHV-6B in three 1212 
saliva samples (SAL035, SAL044 and SAL050). Triplicate reactions for a DR amplicon (DR6B-F and 1213 
DR6B-R primers) and a PAC1 amplicon (PAC1F and PAC1R-33 primers) are shown for each sample. 1214 
The absolute copy number of each amplicon per l ddPCR reaction and the ratio between DR and 1215 
PAC1 amplicons are shown below each plot. 1216 
 1217 
Figure 5. Quantifying iciHHV-6B truncations at DRL-T2 and assessment of the newly formed telomere 1218 
length. (A) Diagram showing the loss of DRL from iciHHV-6B, formation of a novel telomere at DRL-T2 1219 
and the potential lengthening of the newly formed telomere by a telomere maintenance 1220 
mechanism. STELA primers (Teltail and Telorette 2) and the primer UDL6R, in the unique region of 1221 
the iciHHV-6B genome, were used to amplify HHV-6B-associated telomeres. Long STELA products 1222 
(>8.6kb) are generated from intact copies of the iciHHV-6B genome and include amplification 1223 
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through DRL to the end of the telomere. Short STELA products (0.7 - 0.9 kb) are generated when DRL 1224 
has been lost and a novel telomere has formed at DRL-T2. Intermediate sized STELA products are 1225 
generated when the novel telomere formed at DRL-T2 has been lengthened. All three types of STELA 1226 
amplicons contain TTAGGG telomere repeats and hybridise to a telomere repeat probe. The relative 1227 
positions of the DR3 and DR8 probes used to detect DR sequences are shown. (B) Representative 1228 
Southern blots exhibiting amplicons generated by HHV-6B STELA with the UDL6R flanking and 1229 
Telorette 2 primers. Each blot displays products generated from 24-32 parallel STELA PCRs in 1230 
different cell-types from iciHHV-6B carriers. These include a lymphoblastoid cell line (LCL) from 1231 
individual 4B-11p15.5; white blood cells from individual 607009; a pluripotent cell line d37; sperm 1232 
DNA d56. Amplicons detected between the mauve and yellow lines are short STELA products 1233 
(expected size range 0.7 -0.9kb). The bands detected between the yellow and green lines are 1234 
intermediate length STELA products, representative of newly formed telomeres at DRL-T2 that have 1235 
been lengthened. Long STELA amplicons, above the green line, are products generated from full-1236 
length copies of iciHHV-6B and include DRL. (C) Graph showing the estimated number of DRL-T2 1237 
truncations per cell, including those that have been lengthened, in DNA from different iciHHV-6B 1238 
individuals and cell types. Means with standard error and the p-values from a Mann-Whitney ranked 1239 
sum test to compare truncation frequencies (LCL vs other cell-types) are shown. (D) Representative 1240 
UDL6R-STELA blots from the 4B-11p15.5 cell line treated with 0, 100 and 200 ng/mL of trichostatin-A 1241 
(10 parallel STELA PCRs per condition) and a graph showing the frequency of truncations per cell 1242 
(mean and standard error). Data were derived from UDL6R-STELA conducted twice (technical 1243 
replicates) using DNA extracted from treated and untreated cells grown in triplicate (biological 1244 
replicates). p-values were from a Wilcoxon test. (E) DRL-T2 truncation assay on blood DNA from the 1245 
401027 iciHHV-6B carrier demonstrating that the long STELA products (above the green line) contain 1246 
DR sequences that hybridise to the telomere repeat probe (left panel) and the combined DR3/DR8 1247 
probe (right panel). Whereas the intermediate length amplicons (between yellow and green lines) 1248 
only hybridise to the telomere repeat probe (left panel) demonstrating that each amplicon 1249 
represents newly formed telomere at DRL-T2 that has been lengthened. The two Southern blots 1250 
display products detected across 24 parallel STELA PCRS. No short amplicons (0.7-0.9kb) were 1251 
detected in this replicate of the assay for this sample. (F) The graph shows the percentage of newly 1252 
formed telomeres at DRL-T2 that were lengthened in samples from various unrelated iciHHV-6B 1253 
carriers and cell types. Means with standard error and the p-values from a Mann-Whitney ranked 1254 
sum test to compare truncation frequencies (LCL vs other cell-types) are shown. 1255 
 1256 
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Figure 6. Measuring the frequency of iciHHV-6B truncations at DRR-T1 associated with novel 1257 
telomere formation. (A) Schematic of the two-step assay used to differentiate between iciHHV-6B 1258 
associated telomeres at DRR-T1 and DRL-T1. Telomeres at DRR-T1 and DRL-T1 were PCR amplified 1259 
using the STELA primers, DR1R with Telorette 2/Teltail. Subsequently, secondary nested PCRs were 1260 
used to amplify pvT1 (primers DR421 and TJ1F) followed by size separation to distinguish pvT1 from 1261 
DRR-T1 or DRL-T1. (B) Detection of telomeres at DRR-T1 or DRL -T1 in two iciHHV-6B samples 1262 
(NWA008 and 401027) with known length differences between pvT1 in the DRs. Top images show 1263 
telomere amplicons derived from DRL and DRR in the iciHHV-6B samples. The telomeres were 1264 
amplified in 32 parallel STELA PCRs using the DR1R flanking primer and detected by Southern blot 1265 
hybridization to a radiolabeled (TTAGGG)n probe. Lower images show ethidium bromide-stained 1266 
agarose gels of size separated pvT1 sequences amplified from the corresponding STELA reaction in 1267 
track shown in the panel above. White dots identify the PCR reactions that contain pvT1 from DRR-1268 
T1. Below each set of panels are the pvT1 repeat patterns from DRR-T1 or DRL-T1 for the 1269 
corresponding sample, highlighting the differences. (C) Graph showing the frequency of truncations 1270 
and new telomere formation at DRR-T1 in iciHHV-6B samples from unrelated individuals and cell 1271 
types. The number of truncations per cell was calculated using the number of reactions from which 1272 
DRR-pvT1 was amplified divided by the cell equivalents estimated from the total quantity of DNA 1273 
screened (6.6 pg or 3.3 pg DNA per cell was assumed for diploid and haploid cells respectively). 1274 
 1275 
Figure 7. HHV-6B copy number and DRR-pvT1-repeat patterns can be used to identify potential 1276 
iciHHV-6B reactivation and transmission within families. (A) In family Rx-F6a both children are 1277 
iciHHV-6B carriers with approximately one copy per cell. They share the same DRR-pvT1 repeat map, 1278 
presumably inherited from the father (grey filled square, not available for testing). The mother has a 1279 
low level of acqHHV-6B in her saliva (0.00035 copies per cell) and the DRR-pvT1 repeat map is 1280 
different from her children. (B) Evidence of iciHHV-6B reactivation in family Rx-F3a and transmission 1281 
to non-iciHHV-6B son. Left shows the Rx-F3a family tree with HHV-6 copy number per cell in saliva 1282 
DNA and iciHHV-6B carrier status. Father (grey filled square) was not available for testing. Right, the 1283 
DRR-pvT1 repeat patterns from family members. Daughter (G4P3) has two copies of iciHHV-6B, one 1284 
copy shares the same DRR-pvT1 as seen in her mother (G3P2) and a second copy has a different DRR-1285 
pvT1 repeat pattern assumed to have been inherited from her father. The son (G4P1) has a very low 1286 
level of HHV-6B in his saliva with the same pvT1 repeat pattern as the maternal iciHHV-6B genome. 1287 
The DRR-pvT1 repeat patterns are also labeled with m (present in mother); d (present in daughter) 1288 
and s (present in son). The age of tested family members is stated. 1289 
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Figure 1 – figure supplement 1. Complete set of pvT1 interspersion maps from DRR in iciHHV-6B 1290 
(inherited) and acquired HHV-6B (non-inherited) strains. 1291 
The 102 DRR-pvT1 repeat patterns shown demonstrate the diversity among iciHHV-6B (inherited) 1292 
and HHV-6B (acquired) genomes. Ninety of the repeat patterns were unique. As in The TTAGGG  and 1293 
degenerate, telomere-like repeats present in the HHV-6B pvT1 region are colour-coded as follows 1294 
and as shown in Figure 1: Dark green, TTAGGG; brown, CTAGGG; cyan, TTAGTG; yellow, TTACTG; 1295 
dark yellow, ATAGAC; teal, CTAAGG; pink, CTATGG; lime green, TTATGG; blue, GTAGTG; peach, 1296 
TTAGAG; red, GTCTGG. Black squares represent other, less common degenerate repeats and white 1297 
squares show where the sequence could not be determined accurately. Dashes between repeats 1298 
were added to maximize alignment between samples allowing comparison between the proximal, 1299 
central (highly variable) and distal (highly conserved) sections of DRR-pvT1. Repeat maps were 1300 
grouped primarily based on the proximal section, then on less common features within the central 1301 
or distal region, and finally by the length of the central region. Ninety eight of the 102 DRR-pvT1 1302 
repeat patterns are from unrelated individuals and four are from children who have an acqHHV-6B 1303 
that has a different DRR-pvT1 repeat pattern from their parents (blue diamonds). Coloured arrows 1304 
identify 12 repeats patterns found more than once in donors not known to be related. Among eight 1305 
of the identical DRR-pvT1 repeat patterns (blue arrows), seven are in iciHHV-6B genomes predicted 1306 
to be integrated in the 9q telomere and one in an acquired HHV-6B in SAL030. Two others, in 1307 
NWA008 and DER512 from the UK, have a 17p iciHHV-6B integration and share identical DRR-pvT1 1308 
repeat patterns. In addition,  the acquired HHV-6B strains in SAL023 and TEL-FA G1P1 share the 1309 
same DRR-pvT1 repeat pattern.  1310 
Black boxes surround repeat maps from iciHHV-6Bs predicted to have the same integration site, by 1311 
whole viral genome sequence homology, FISH, or subtelomere-iciHHV-6B junction sequence. 1312 
Notably within integration groups there are often shared characteristic features in the DRR-pvT1 1313 
repeat patterns.  1314 
Black dots indicate iciHHV-6B samples where DRR-pvT1 could not be used to predict the integration 1315 
site confidently. For example, the DRR-pvT1 in iciHHV-6B in d32 has a unique distal section and is 1316 
unlikely to share common ancestry with any of the other iciHHV-6B carriers analysed.  1317 
Yellow diamond identifies the DRR-pvT1 repeat pattern in family Rx-F3a, transmitted from iciHHV-6B 1318 




Figure 1 – figure supplement 2. HHV-6B strain identification using DRR-pvT1 repeat patterns in eight 1322 
families, suggests that transmission of acqHHV-6B is predominantly from parents.  1323 
The key to the repeat pattern is the same as in Figure 1. Pedigree symbols shaded blue indicate the 1324 
child(ren) had the same acqHHV-6B DRR-pvT1 repeat pattern as their mother and yellow indicates it 1325 
was the same as their father. The pedigree symbols shaded grey identify individuals from whom the 1326 
pvT1 region could not be amplified. The green symbols identify children that do not share a DRR-1327 
pvT1 map with either parent and the dark green symbol for TEL-FM G2P1 indicates that this 1328 
individual had a DRR-pvT1 that was different to their siblings and parents. TEL-FL G2P2 (asterisk) has 1329 
a DRR-pvT1 repeat pattern that differs from that in their mother by a gain of two repeats (CTAGGG-1330 
TTAGGG) in the central section.  1331 
 1332 
 1333 
Figure 2 – figure supplement 1. Examples of views taken from the HHV-6 Explorer.  1334 
The HHV-6 explorer allows different types of variation across iciHHV-6A/6B and acquired HHV-6A/6B 1335 
genomes from different individuals to be compared against a reference genome. The user can select 1336 
the size of overlapping or non-overlapping sliding windows in an upper and lower graph to allow 1337 
easier comparison when a larger number of genomes are selected from the drop-down menus. After 1338 
selecting the type(s) of variation and genomes to be explored, an upper and lower Genome View 1339 
graph will be generated based on the user-selected sliding window size. The Genome View can show 1340 
the specified type(s) of variation across the whole or part of the genome, as a count of mutations 1341 
per window size (100 bp, non-overlapping window in the examples shown). Cumulative mutations 1342 
per window size are shown if multiple types of variation are selected. Each genome is assigned a 1343 
unique colour and where part of sequence is missing, a value of negative one will be assigned for 1344 
that particular window and the bar on the graph will be red.  1345 
A) In the examples shown, iciHHV-6A and acquired HHV-6A genomes have been compared to 1346 
GLA_25506 (19q iciHHV-6A) as the reference. The left and right top panels allow different samples to 1347 
be selected for comparison to the reference and in both examples, truncations (i.e. a nonsense 1348 
mutation encoding a premature stop codon) are displayed. In the examples shown, seven 17p 1349 
iciHHV-6A genomes have been selected to be displayed on the lower graph and a variety of acquired 1350 
HHV-6A and 18q, 19q and 22q iciHHV-6A genomes have been selected to be displayed on the upper 1351 
graph. The Genome View is zoomed in to show a region displaying truncations in U79 in three 17p 1352 
iciHHV-6A genomes (303-046, 303-035 and GLA_15137). In the HHV-6 Explorer the next graph 1353 
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generated is the Gene View where a single gene of interest can be selected to view variation at the 1354 
amino acid level, U79 in this case. The final plot on the HHV-6 Explorer is the Gene Alignment, based 1355 
on an alignment of all iciHHV-6A and acquired HHV-6A (or iciHHV-6B and acquired HHV-6B) used to 1356 
generate the phylogenetic networks. In this region of U79, the sequence assemblies are missing data 1357 
in 13 of the viral genomes (dashes). The exact amino acid position of the premature stop codon for 1358 
303-035 is highlighted, underscore at amino acid 431. All other iciHHV-6A/HHV-6A genomes (for 1359 
which sequence is available) lack this premature stop codon, including other 17p iciHHV-6A genomes 1360 
(e.g. 7A-17p13.3) indicating that this mutation arose after integration. Black dots identify the 17p-1361 
iciHHV-6A samples with sequence across U79. 1362 
B) iciHHV-6B and acquired HHV-6B genomes have been compared to HST (acquired HHV-6B), a 1363 
reference strain. The images taken from the HHV-6 Explorer are displayed as for panel A. Members 1364 
of the iciHHV-6B 17p (minor) integration group are displayed in the upper graphs and a variety of 1365 
other iciHHV-6B integrations and acquired HHV-6B genomes are displayed on the lower graphs. A 1366 
premature stop codon is present at position 116 in U14 in 1B-iciHHV-6B but not in 704-021 or 704-1367 
016, which share the same common ancestor. Again, this indicates that the nonsense mutation 1368 
arose after integration. Black dots identify the 17p(minor)-iciHHV-6B genomes. 1369 
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 1371 
Figure 5 – figure supplement 1. Detect of excised circular DR-only molecules, sequencing of a 1372 
lengthened new telomere at DRL-T2 and detection of telomerase activity. 1373 
(A) Schematic of DR-circle assay. DR-circles were amplified using primers (DR8F(A/B) and DR3R) that 1374 
should not generate a PCR product from full-length iciHHV-6B but should amplify across telomere 1375 
repeats in a DR-circle, the predicted reciprocal product of a t-loop mediated excision event at DRL-1376 
T2. Genomic DNA from two iciHHV-6B individuals (1B-iciHHV-6B and 4B-11p15.5) was digested with 1377 
combinations of restriction enzymes that cut in the unique region and DR (X: SacI and PstI), only the 1378 
unique region (Y: XbaI and ScaHF) or were not treated with restriction enzymes. Treated DNA was 1379 
amplified using DR8F(A/B) and DR3R, and PCR products were size separated and detected by 1380 
Southern blot hybridized to a radiolabelled (TTAGGG)n telomere probe. Amplicons of variable length 1381 
were detected reflecting different lengths of telomere repeat arrays expected in individual DR-1382 
circles. Restriction digestion with SacI/PstI, including between DR8F(A/B) and T2,  prevents 1383 
amplification from DR-circles. Importantly, the minimal size of amplicons detected was greater than 1384 
the combined length of the flanking regions. Full length 4B-11p15.5 had longer average telomere 1385 
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length at DRL-T1 than 1B-iciHHV-6B, which is consistent with the longer products generated in the 1386 
DR-circle assay.  1387 
(B) The schematic shows how newly formed telomeres at DRL-T2 were detected and sequenced. 1388 
UDL6R-STELA was used to amplify telomeres at DRL-T2 and it occasionally amplified telomeres that 1389 
were longer than the length of DRL-T2. Six of these intermediate length STELA products from three 1390 
different DNA samples were re-amplified in a semi-nested, secondary PCR using primer DR8RT2 and 1391 
Telorette 2. Following gel extraction these products were Sanger sequenced using DR8RT2 or 1392 
Telorette 2. The TTAGGG repeats were visualized with FinchTV and counted manually. 1393 
Electropherograms from one reamplified molecule from NWA008 are shown. As expected, the PAC2 1394 
motif was present (boxed sequence). A black line at base 273 shows where DRL-T2 in this sample was 1395 
expected to end (after 18 TTAGGG repeats). Over 100 telomere repeats were counted from 1396 
Telorette 2, considerably more than the length of T2 showing that this telomere has been 1397 
lengthened. 1398 
(C) Detecting telomerase activity in iciHHV-6B lymphoblastoid cell lines. Telomere repeat 1399 
amplification protocol (TRAP) was used to detect low levels of telomerase activity in various iciHHV-1400 
6B lymphoblastoid cell lines. Water and CHAPS were used as negative controls and cell lysate from a 1401 
telomerase positive HUV-EC cell line was used as a positive control.  1402 
 1403 
 1404 
Figure 6 – figure supplement 1. The majority of iciHHV-6B genomes show sequence differences 1405 
between DRR-pvT1 and DRL-pvT1.  1406 
DRR-T1 and DRL-T1 were specifically amplified by PCR using DR1R and U100Fw2 for DRR-T1, or by 1407 
STELA using DR1R and STELA oligonucleotides (Teltail and Telorette 2) for DRL-T1. The products from 1408 
DRR-T1 and DRL-T1 specific PCRs were used as input  for secondary, nested PCR using DR421R and 1409 
TJ1F to specifically amplify DRR-pvT1 and DRL-pvT1. Sanger sequencing was carried out using the TJ1F 1410 
primer. Sequences were manually examined to generate pvT1 repeat patterns. Repeats patterns 1411 
were colour coded and aligned as in Figure 1 and figure supplement 1. The majority of iciHHV-6B 1412 
genomes (24/35, 68.6%) showed differences between DRR-pvT1 and DRL-pvT1, usually as loss or gain 1413 
of a small number of hexameric telomere (TTAGGG) or degenerate telomere-like repeats. In a 1414 
smaller number of cases, a single base change converted one repeat type to another. Regions 1415 
containing CTAGGG repeats were most prone to loss or gain of repeats. Where differences between 1416 
DRR-pvT1 and DRL-pvT1 were detected in multiple iciHHV-6B genomes from the same integration 1417 
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group (boxed) the differences were rarely the same between individuals. This indicates that the 1418 
differences arose after integration. Interestingly, 9q iciHHV-6B genomes did not display any variation 1419 
between DRR-pvT1 and DRL-pvT1. 1420 
 1421 
 1422 
Figure 7 – figure supplement 1.  1423 
Quantification of HHV-6B using POL (U38) ddPCR in two families (Rx-3FA and Rx-6Fa ) 1424 
HHV-6B copy number was estimated in Rx-3Fa and Rx-6Fa family members using a duplex hydrolysis 1425 
probe ddPCR assay. 1D ddPCR plots for HHV-6B U38 and human reference RPP30 for three 1426 
individuals in each family are shown. Each point represents a single droplet in which amplification of 1427 
the target has occurred (blue or green) or has not occurred (grey). HHV-6B free cell line HT1080 and 1428 
water were used as negative controls. Estimated copy numbers are shown below plots along with 1429 
HHV-6B status.  1430 
 1431 














